Lequient Frederic
Known title: SVP Global Customer ServicesCIK: 0001670015
Associated companies
Transaction History
| VEEV | ▲ Buy | Option Exercise | 1,177 | $0 | 8/27/2022 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 408 | $84K | 8/27/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 637 | $0 | 4/1/2022 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 221 | $48K | 4/1/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 638 | $0 | 1/1/2022 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 257 | $66K | 1/1/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 637 | $0 | 10/1/2021 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 316 | $91K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veeva Gains Investor Attention Amid R&D Growth and AI Focus
Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.
Veeva Gains Investor Attention Amid R&D Growth and AI Focus. Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.